2023 Neurotech Leaders Forum
November 6-7, 2023
Embassy Suites, San Francisco Airport Waterfront and Zoom
Tentative Agenda (all times PST)
Day One
8:00-8:30 |
Registration and Coffee |
8:30-9:15 |
State of the Neurotechnology Industry: 2023James Cavuoto, Editor and Publisher, Neurotech ReportsNeurotech Business Report Editor James Cavuoto provides his insights and observations on the state of the neurotechnology industry. He surveys changes in the competitive landscape that have occurred over the years, the most significant events of the last year, and challenges confronting the industry in years ahead. |
9:15-10:00 |
Keynote AddressJames Schuermann, CEO, Saluda Medical Inc.New Directions in Neuromodulation |
10:00-10:30 |
Refreshment Break |
10:30-11:15 |
Neurotech Investment Outlook: Bouncing Back from the DownturnJo Jo Platt, Senior Contributing Editor, Neurotech Reports, ModeratorSara Shnider, Ph.D., U.S. Academic Innovation Lead, Joy VenturesSuraj Mudichintala, Senior Associate, Action Potential Venture CapitalMartin Dieck, Founding Director, Neurotechnology InvestorsThe neurotech investment climate took a slight dip in the last year, but there are signs that conditions may improve in the years ahead. In this session, investors will offer their insights on what lies ahead for startups. |
11:15-12:00 |
Changing Landscape: New SCS and PNS Vendors Enter the SceneJeremy Koff, Senior Consulting Editor, Neurotech Reports, ModeratorTodd Langevin, President, Biotronik NeuroAlex Yeh, Ph.D., Founder and CTO, Neuspera Medical Inc.Victor Pikov, Ph.D., CEO, Medipace Inc.With the introduction of Biotronik and Saluda Medical to the U.S. market for spinal cord stimulation systems, plus the emergence of several new PNS vendors, the competitive outlook in the neuromodulation industry is likely to undergo significant change in the year ahead. In this session, we'll examine the impact of these new players and assess the outlook for consolidation and M&A activity. |
12:00-1:30 |
Luncheon, Sponsored by Cirtec Medical |
1:30-3:00 |
Neurotechnology Entrepreneur PanelJames Cavuoto, Editor, Neurotech Reports, ModeratorBen Woodington, Ph.D., CEO, Opto BiosystemsDaniel Powell, CEO, Spark BiomedicalDave Singhal, CEO, PainVoxRobert Greenberg, M.D., Ph.D., CEO, huMannity MedtecJonatahn O'Keeffe, Ph.D., Founder and CEO, Machine MedicineThis session features presentations from CEOs and executives of several neurotechnology start-up firms and more established technology ventures. Each executive will present an overview of their firm's technology and markets. |
3:00-3:30 |
Refreshment Break |
3:30-4:15 |
Choosing Our Role Models: What Neurotech Can Learn from Other Healthcare IndustriesVictor Pikov, Contributing Editor, Neurotech Reports, ModeratorMarco Sorani, Ph.D., Executive Director, Development Sciences, Genentech, Inc.David Groves, Contributing Editor, BioElectRx Business ReportWhile the neurotechnology market has matured considerably in recent years, it is still dwarfed by larger segments of the healthcare industry. In this session, seasoned representatives of related fields such as cardiac devices and pharmaceuticals will offer their insights on commonalities and differences that could prove relevant. |
4:15-5:00 |
Interpreting the Data: Neuromodulation Vendors Ward Off Negative PublicationsJames Cavuoto, Editor, Neurotech Reports, ModeratorPrasad Shirvalkar, M.D., Ph.D., Associate Professor, Anesthesia, UC San Francisco School of MedicineSanket Dhruva, M.D., Assistant Professor, Cardiology, UC San Francisco School of MedicineEric Grigsby M.D., Founder and Medical Director, Napa Pain InstituteThe neuromodulation industry has come under attack from several negative studies and publications casting doubt on the efficacy of SCS and related therapies. In this session, we'll discuss efforts to counteract this negativity and explore the role that insurance industry interests have played in the controversy. |
5:00-7:00 |
Cocktail Reception, Sponsored by MST |
Day Two
8:00:8:30 |
Registration and Coffee |
8:30-9:15 |
Keynote AddressDaniel Kraft, M.D., Founder and Chair, NextMed HealthThe Future of Health and Medicine: Where Can Technology Take Us? |
9:15-10:00 |
Wearables Update: Noninvasive Neuromodulation Takes New FormsSharena Rice, Ph.D., Contributing Editor, Neurotech Reports, ModeratorJamie Tyler, Ph.D., Professor of Neuroengineering, University of Alabama, BirminghamKamran Ansari, Co-Founder & CEO, FluxWearThe market for noninvasive neuromodulation continues to exapnd, as new vendors and new technologies enter the marketplace. In this session, we'll examine the impact of alternative forms of neuromodulation, such as optical, magnetic, and focused ultrasound, on the existing wearables segment. |
10:00-10:30 |
Coffee Break |
10:30-11:15 |
Walking the Walk: Paralysis Community Rises Up with NeurotechJames Cavuoto, Editor, Neurotech Reports, ModeratorMarco Sorani, Ph.D., Executive Director, Development Sciences, Genentech, Inc.Andreas Forsland, CEO, CognixionErika Ross Ellison, Ph.D., Vice President, Clinical, Regulatory, and Quality, ONWARDSeveral vendors and research institutions developing advanced neuroprosthetics systems have offered hope to many individuals with disorders such as spinal cord injury, ALS, and stroke. In this session, we'll look at some of the recent developments in this space and discuss the role that the disability community can play in promoting progress. |
11:15-12:00 |
Healing the Mind: New Indications Emerge for Neuromodulation TherapiesJoJo Platt, Senior Contributing Editor, Neurotech Reports, ModeratorNolan Williams, M.D., Associate Professor of Psychiatry and Behavioral Sciences, Stanford UniversitySteven Goetz, CTO, Motif NeurotechBrandon Bentzley, M.D., Ph.D., CSO, Magnus MedicalChristopher Rozell, Professor and Chair, Electrical and Computer Engineering, Georgia Instititue of TechnologyVendors of implanted and wearable neuromodulation devices have made significant strides developing new therapies for psychiatric disorders. In this session we'll offer attendees an update on the most significant developments. |
12:00-1:30 |
Luncheon, Sponsored by Cirtec MedicalPresentation of 2023 Gold Electrode Awards |
1:30-3:00 |
Neurotechnology Entrepreneur PanelJames Cavuoto, Editor, Neurotech Reports, ModeratorKeith Warner, CEO, NeuraLace MedicalAmy Baxter, M.D., CEO, Harmonic Pain SolutionsNicolas Barabino, Ph.D., Consultant, FocusJay Sanguinetti, Co-founder and CEO, Sanmai TechnologiesThis session features presentations from CEOs and executives of several neurotechnology start-up firms and more established technology ventures. Each executive will present an overview of their firm's technology and markets. |
3:00-3:30 |
Refreshment Break |
3:30-4:15 |
Partners in Progress: Neurotech Suppliers Help Startups Get LaunchedJeremy Koff, Senior Consulting Editor, Neurotech Reports, ModeratorBrian Highley, CEO, Cirtec MedicalEran Benjamin, Business Development Manager, Micro Systems TechnologiesUli Gommel, CTO, Neo-BionicaNeurotech startups can save a considerable amount of time and expense by taking advantage of suppliers of key components such as power sources, interconnects, enclosures, and leads. In this session, we'll ask suppliers to cite one example of how they helped a neurotech startup hit the ground running. |
4:15-5:00 |
Facing the Public: An Editorial PerspectiveJames Cavuoto, Editor and Publisher, Neurotech Reports, ModeratorJeremy Koff, Senior Consulting Editor, Neurotech ReportsJo Jo Platt, Senior Contributing Editor, Neurotech ReportsSharena Rice, Ph.D., Contributing Editor, Neurotech ReportsVictor Pikov, Ph.D., Contributing Editor, BioElectRx Business ReportIn this wrap-up session, Neurotech Reports team of editors will offer their views on recent controversies facing the neuromodulation industry, including ethical concerns, dealing with bad press, and legislative and regulatory developments. |
5:00-7:00 |
Cocktail Reception, Sponsored by MST |